Novartis signs world’s first licensing deal for high-priced cancer drug – Novartis AG agreed to allow generic drugmakers in 7 middle-income nations to produce a leukemia treatment as part of a public health initiative, the first time a voluntary license has been granted for a patented cancer drug.
- The oral drug called nilotinib is used to treat chronic myeloid leukemia.
- The Medicines Patent Pool aims to boost access to medicine for people.
★★★★ You Can Also Read ★★★★
| Computer Awareness Quiz Questions Set (Banking) |
| Read Daily Current Affairs Topic Wise |
| Daily Current Affairs Quiz (Current GK Test) |
| Static Gk Quiz Questions and Answers |
📣 Prepare Exams is now on Facebook, Twitter, Instagram, YouTube Channel, and Google News to get all the latest News first Like, Follow and bookmark our website @ PrepareExams.com.
For all the latest Updates, download PrepareExams App.